Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the benzocycloheptapyridine class. It has the molecular formula C24H29ClN4O2S and a molecular weight of approximately 473.03 g/mol. The structure features a chlorinated aromatic system fused with piperazine and methylsulfonyl-substituted piperidine rings. It is catalogued as an experimental compound in several chemical databases (DrugBank DB07216; CHEMBL372164) but has not been approved for any therapeutic use or entered clinical trials beyond preclinical research phases. No mechanism of action or biological target information is available in public sources as of now.[1][9][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (11S)-8-chloro-11-[1-(methylsulfonyl)piperidin-4-yl]-6-piperazin-1-yl-11H-benzo[5,6]cyclohepta[1,2-b]pyridine.